01652 FUSEN PHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.56X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 2.1% | Net Margin | N/A |
| Total Debt/Equity | 83.9% | Return on Equity | N/A |
| Price/Book | 2.33X | Return on Assets | N/A |
| (HKD 1.260) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -13.12 | -200.77 | -39.98 | -38.80 | 20.36 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +93.5 | -402.1 | -3.1 | -290.6 | -75.5 |
| Earnings Per Share (HKD) | -0.018 | -0.271 | -0.053 | -0.051 | 0.027 |
| Earnings Per Share Growth (%) | +93.5 | -410.0 | -3.7 | -293.6 | -75.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | 0.011 |
| P/E* (X) | N/A | N/A | N/A | N/A | 47.55 |
| Yield (%) | N/A | N/A | N/A | N/A | 0.87 |
| Dividend Share (%) | N/A | N/A | N/A | N/A | 41.51 |
| Book NAV (HKD) | 0.541 | 0.532 | 0.828 | 0.908 | 1.046 |
| Auditors' Opinion | N/A | Unqualified # | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 273.365 | 326.029 | -16.2 | 565.608 |
| Operating Result | -22.056 | -86.352 | -74.5 | -8.032 |
| Associates | 14.453 | -104.097 | -113.9 | -20.292 |
| Profit Before Taxation | -7.603 | -190.446 | -96.0 | -29.448 |
| Taxation | 4.198 | -1.646 | -355.0 | 6.847 |
| Profit /( Loss) After Taxation | -11.801 | -188.8 | -93.7 | -36.295 |
| Minority Interests | -0.017 | -0.017 | +0.0 | -0.018 |
| Net Profit | -11.784 | -188.783 | -93.8 | -36.277 |
| Earnings Per Share () | -0.0177 | -0.2713 | -93.5 | -0.0532 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2026-03-31 | 2025-03-31 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
